1. Home
  2. NTRA vs STM Comparison

NTRA vs STM Comparison

Compare NTRA & STM Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Natera Inc.

NTRA

Natera Inc.

HOLD

Current Price

$235.55

Market Cap

27.0B

Sector

Health Care

ML Signal

HOLD

Logo STMicroelectronics N.V.

STM

STMicroelectronics N.V.

HOLD

Current Price

$25.94

Market Cap

28.2B

Sector

Technology

ML Signal

HOLD

Company Overview

Basic Information
Metric
NTRA
STM
Founded
2003
1987
Country
United States
Netherlands
Employees
N/A
N/A
Industry
Medical Specialities
Semiconductors
Sector
Health Care
Technology
Exchange
Nasdaq
Nasdaq
Market Cap
27.0B
28.2B
IPO Year
2015
1994

Fundamental Metrics

Financial Performance
Metric
NTRA
STM
Price
$235.55
$25.94
Analyst Decision
Strong Buy
Buy
Analyst Count
15
7
Target Price
$235.87
$32.60
AVG Volume (30 Days)
1.4M
6.3M
Earning Date
11-06-2025
01-29-2026
Dividend Yield
N/A
1.24%
EPS Growth
N/A
N/A
EPS
N/A
0.58
Revenue
$2,116,676,000.00
$11,792,000,000.00
Revenue This Year
$32.77
N/A
Revenue Next Year
$16.51
$10.76
P/E Ratio
N/A
$44.47
Revenue Growth
38.17
N/A
52 Week Low
$125.38
$17.25
52 Week High
$246.90
$33.47

Technical Indicators

Market Signals
Indicator
NTRA
STM
Relative Strength Index (RSI) 62.25 57.83
Support Level $221.84 $25.49
Resistance Level $232.76 $26.29
Average True Range (ATR) 6.35 0.54
MACD -2.11 0.10
Stochastic Oscillator 54.71 62.20

Price Performance

Historical Comparison
NTRA
STM

About NTRA Natera Inc.

Natera Inc is a diagnostic and research company with proprietary molecular and bioinformatics technology. The company's key product offerings include its Panorama Non-Invasive Prenatal Test (NIPT) which screens for chromosomal abnormalities of a fetus as well as in twin pregnancies, typically with a blood draw from the mother, Horizon Carrier Screening (HCS) to determine carrier status for a large number of severe genetic diseases that could be passed on to the carrier's children, Signatera molecular residual disease (MRD) test, which detects circulating tumor DNA in patients previously diagnosed with cancer to assess molecular residual disease and monitor for recurrence; and Prospera, to assess organ transplant rejection.

About STM STMicroelectronics N.V.

A merger between Italian firm SGS Microelettronica and the nonmilitary business of Thomson Semiconducteurs in France formed STMicroelectronics in 1987. STMicroelectronics is a leader in a variety of semiconductor products, including analog chips, discrete power semiconductors, microcontrollers, and sensors. It is an especially prominent chip supplier to the industrial and automotive industries.

Share on Social Networks: